Back
Crinetics Pharmaceuticals Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
68
CRNX
Crinetics Pharmaceuticals
Last Price:
59.10
Seasonality Move:
10.45%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Crinetics Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.8 | Buy |
| 20-day SMA: | 56.29 | Buy |
| 50-day SMA: | 53.83 | Buy |
| 200-day SMA: | 47.57 | Buy |
| 8-day EMA: | 56.99 | Buy |
| 20-day EMA: | 56.2 | Buy |
| 50-day EMA: | 54.33 | Buy |
| 200-day EMA: | 47.18 | Buy |
Crinetics Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 59.55 | Buy |
| Chaikin Money Flow: | 308844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.77 - 58.39) | Buy |
| Bollinger Bands (100): | (47.89 - 55.75) | Buy |
Crinetics Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Crinetics Pharmaceuticals Stock
Is Crinetics Pharmaceuticals Stock a Buy?
- Crinetics Pharmaceuticals share price is 57.81 while CRNX 8-day simple moving average is 56.80, which is a Buy signal.
- The stock price of CRNX is 57.81 while Crinetics Pharmaceuticals 20-day SMA is 56.29, which makes it a Buy.
- Crinetics Pharmaceuticals 50-day simple moving average is 53.83 while CRNX share price is 57.81, making it a Buy technically.
- CRNX stock price is 57.81 and Crinetics Pharmaceuticals 200-day simple moving average is 47.57, creating a Buy signal.
CRNX Technical Analysis vs Fundamental Analysis
Buy
68
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a Buy
The current Crinetics Pharmaceuticals [CRNX] share price is $57.81. The Score for CRNX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Crinetics Pharmaceuticals Stock Info
Market Cap:
4.63B
Price in USD:
57.81
Share Volume:
326.42K
Crinetics Pharmaceuticals 52-Week Range
52-Week High:
60.04
52-Week Low:
25.75
Buy
68
Crinetics Pharmaceuticals (CRNX)
is a Buy
Crinetics Pharmaceuticals Share Price Forecast
-
What is the Crinetics Pharmaceuticals stock price today?
The Crinetics Pharmaceuticals stock price is 57.81 USD today. -
Will CRNX stock go up or go down?
Crinetics Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Crinetics Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Crinetics Pharmaceuticals is not overvalued.
Is Crinetics Pharmaceuticals Stock a Buy?
- Crinetics Pharmaceuticals share price is 57.81 while CRNX 8-day exponential moving average is 56.99, which is a Buy signal.
- The stock price of CRNX is 57.81 while Crinetics Pharmaceuticals 20-day EMA is 56.20, which makes it a Buy.
- Crinetics Pharmaceuticals 50-day exponential moving average is 54.33 while CRNX share price is 57.81, making it a Buy technically.
- CRNX stock price is 57.81 and Crinetics Pharmaceuticals 200-day simple moving average is 47.18, creating a Buy signal.
Fundamental Analysis of Crinetics Pharmaceuticals
Is Crinetics Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
Technical Analysis of Crinetics Pharmaceuticals
Should I short Crinetics Pharmaceuticals stock?
- CRNX Moving Average Covergence Divergence (MACD) indicator is 1.06, suggesting Crinetics Pharmaceuticals is a Buy
- Crinetics Pharmaceuticals Relative Strength Index (RSI) is 59.55, which suggest Crinetics Pharmaceuticals is overbought
- The Bollinger Bands (25) for Crinetics Pharmaceuticals is (52.77 - 58.39), which suggest Crinetics Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Crinetics Pharmaceuticals is (47.89 - 55.75), which suggest Crinetics Pharmaceuticals is a Buy
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.